OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AOXI55

Aoxin Q & M Dental Group Ltd

Healthcare Facilities & ServicesVerified

Aoxin Q & M Dental Group Ltd maintains a strong liquidity position, with a current ratio of 7.82, indicating that it holds significantly more current assets than current liabilities. The company's cash and equivalents amount to CNY 148.7 million, which is a substantial portion of its total assets of CNY 383.5 million. The debt-to-equity ratio is low at 0.04, suggesting minimal reliance on debt financing and a conservative capital structure. In terms of profitability, the company's return on equity (ROE) is 2.0%, and its return on assets (ROA) is 1.82%. These figures are below the typical thresholds for high-performing healthcare service providers, indicating that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in a single business segment, which is its dental services and clinic operations. There is no disclosed geographic diversification, and the company's operations are primarily based in China. This concentration may expose the company to regional economic and regulatory risks. Looking ahead, the company's revenue is expected to grow, supported by the increasing demand for dental services in China. However, the growth trajectory is not yet quantified in the available data. The company's operating cash flow of CNY 4.14 million and free cash flow of CNY 19.5 million suggest that it has the capacity to fund operations and potentially invest in expansion. The company's risk profile is characterized by low liquidity and dilution risks. There are no immediate filing-based liquidity or dilution flags, and the company's capital structure is stable with a low debt-to-equity ratio. The absence of dilution risk is further supported by the fact that the number of shares outstanding is the same for both basic and diluted shares. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company continues to operate its dental clinics and provide outpatient dental services, with no disclosed major events or strategic shifts in the latest available data.

30-day price · AOXI+0.06 (+31.4%)
Low$0.18High$0.27Close$0.26As of14 May, 00:00 UTC
Profile
CompanyAoxin Q & M Dental Group Ltd
TickerAOXI.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Aoxin Q & M Dental Group Ltd provides dental services and operates dental clinics in China, generating revenue primarily through outpatient dental treatments and procedures.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Aoxin Q & M Dental Group Ltd maintains a strong liquidity position, with a current ratio of 7.82, indicating that it holds significantly more current assets than current liabilities. The company's cash and equivalents amount to CNY 148.7 million, which is a substantial portion of its total assets of CNY 383.5 million. The debt-to-equity ratio is low at 0.04, suggesting minimal reliance on debt financing and a conservative capital structure. In terms of profitability, the company's return on equity (ROE) is 2.0%, and its return on assets (ROA) is 1.82%. These figures are below the typical thresholds for high-performing healthcare service providers, indicating that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in a single business segment, which is its dental services and clinic operations. There is no disclosed geographic diversification, and the company's operations are primarily based in China. This concentration may expose the company to regional economic and regulatory risks. Looking ahead, the company's revenue is expected to grow, supported by the increasing demand for dental services in China. However, the growth trajectory is not yet quantified in the available data. The company's operating cash flow of CNY 4.14 million and free cash flow of CNY 19.5 million suggest that it has the capacity to fund operations and potentially invest in expansion. The company's risk profile is characterized by low liquidity and dilution risks. There are no immediate filing-based liquidity or dilution flags, and the company's capital structure is stable with a low debt-to-equity ratio. The absence of dilution risk is further supported by the fact that the number of shares outstanding is the same for both basic and diluted shares. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company continues to operate its dental clinics and provide outpatient dental services, with no disclosed major events or strategic shifts in the latest available data.
Key takeaways
  • Aoxin Q & M Dental Group Ltd has a strong liquidity position with a current ratio of 7.82 and a low debt-to-equity ratio of 0.04.
  • The company's return on equity and return on assets are modest, at 2.0% and 1.82%, respectively.
  • Revenue is concentrated in a single business segment, with no disclosed geographic diversification.
  • The company has low liquidity and dilution risks, with no immediate filing-based flags.
  • The company's operations are primarily based in China, which may expose it to regional economic and regulatory risks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$171.0M
Gross profit$113.2M
Operating income$10.7M
Net income$7.0M
R&D
SG&A
D&A
SBC
Operating cash flow$4.1M
CapEx-$2.2M
Free cash flow$19.5M
Total assets$383.5M
Total liabilities$34.7M
Total equity$348.8M
Cash & equivalents$148.7M
Long-term debt$12.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$348.8M
Net cash$136.2M
Current ratio7.8
Debt/Equity0.0
ROA1.8%
ROE2.0%
Cash conversion59.0%
CapEx/Revenue-1.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
MetricAOXIActivity
Op margin6.2%5.6% medp25 -4.2% · p75 12.6%above median
Net margin4.1%2.8% medp25 -3.4% · p75 8.8%above median
Gross margin66.2%36.5% medp25 23.7% · p75 65.2%top quartile
CapEx / revenue-1.3%-4.9% medp25 -11.5% · p75 -2.0%top quartile
Debt / equity4.0%69.3% medp25 7.9% · p75 120.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 00:13 UTC#9223073c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 09:05 UTCJob: deba674f